Nuclear lncRNA CERNA1 enhances the cisplatin-induced cell apoptosis and overcomes chemoresistance via epigenetic activation of BCL2L10 in ovarian cancer
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
KeAi Communications Co., Ltd.
2023-01-01
|
Series: | Genes and Diseases |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352304222000125 |
_version_ | 1797702695862140928 |
---|---|
author | Rui Xu Hui Peng Ning Yang Zhenping Liu Wei Lu |
author_facet | Rui Xu Hui Peng Ning Yang Zhenping Liu Wei Lu |
author_sort | Rui Xu |
collection | DOAJ |
first_indexed | 2024-03-12T04:54:38Z |
format | Article |
id | doaj.art-48bfeae392ca41cc855bec5d5baeabfc |
institution | Directory Open Access Journal |
issn | 2352-3042 |
language | English |
last_indexed | 2024-03-12T04:54:38Z |
publishDate | 2023-01-01 |
publisher | KeAi Communications Co., Ltd. |
record_format | Article |
series | Genes and Diseases |
spelling | doaj.art-48bfeae392ca41cc855bec5d5baeabfc2023-09-03T09:15:48ZengKeAi Communications Co., Ltd.Genes and Diseases2352-30422023-01-011011013Nuclear lncRNA CERNA1 enhances the cisplatin-induced cell apoptosis and overcomes chemoresistance via epigenetic activation of BCL2L10 in ovarian cancerRui Xu0Hui Peng1Ning Yang2Zhenping Liu3Wei Lu4Key Laboratory of Gynecologic Oncology of Shandong Province, Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, Jinan, Shandong 250012, China; Department of Clinical Laboratory Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250021, China; Department of Clinical Laboratory Medicine, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, ChinaDepartment of Obstetrics and Gynecology, The Fifth People's Hospital of Jinan, Jinan, Shandong 250022, ChinaKey Laboratory of Gynecologic Oncology of Shandong Province, Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, Jinan, Shandong 250012, China; Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, Jinan, Shandong 250012, China; Shandong Engineering Laboratory for Urogynecology, Qilu Hospital of Shandong University, Jinan, Shandong 250012, ChinaKey Laboratory of Gynecologic Oncology of Shandong Province, Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, Jinan, Shandong 250012, China; Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, Jinan, Shandong 250012, China; Shandong Engineering Laboratory for Urogynecology, Qilu Hospital of Shandong University, Jinan, Shandong 250012, ChinaKey Laboratory of Gynecologic Oncology of Shandong Province, Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, Jinan, Shandong 250012, China; Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, Jinan, Shandong 250012, China; Shandong Engineering Laboratory for Urogynecology, Qilu Hospital of Shandong University, Jinan, Shandong 250012, China; Corresponding author. Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, Jinan, Shandong 250012, China.http://www.sciencedirect.com/science/article/pii/S2352304222000125 |
spellingShingle | Rui Xu Hui Peng Ning Yang Zhenping Liu Wei Lu Nuclear lncRNA CERNA1 enhances the cisplatin-induced cell apoptosis and overcomes chemoresistance via epigenetic activation of BCL2L10 in ovarian cancer Genes and Diseases |
title | Nuclear lncRNA CERNA1 enhances the cisplatin-induced cell apoptosis and overcomes chemoresistance via epigenetic activation of BCL2L10 in ovarian cancer |
title_full | Nuclear lncRNA CERNA1 enhances the cisplatin-induced cell apoptosis and overcomes chemoresistance via epigenetic activation of BCL2L10 in ovarian cancer |
title_fullStr | Nuclear lncRNA CERNA1 enhances the cisplatin-induced cell apoptosis and overcomes chemoresistance via epigenetic activation of BCL2L10 in ovarian cancer |
title_full_unstemmed | Nuclear lncRNA CERNA1 enhances the cisplatin-induced cell apoptosis and overcomes chemoresistance via epigenetic activation of BCL2L10 in ovarian cancer |
title_short | Nuclear lncRNA CERNA1 enhances the cisplatin-induced cell apoptosis and overcomes chemoresistance via epigenetic activation of BCL2L10 in ovarian cancer |
title_sort | nuclear lncrna cerna1 enhances the cisplatin induced cell apoptosis and overcomes chemoresistance via epigenetic activation of bcl2l10 in ovarian cancer |
url | http://www.sciencedirect.com/science/article/pii/S2352304222000125 |
work_keys_str_mv | AT ruixu nuclearlncrnacerna1enhancesthecisplatininducedcellapoptosisandovercomeschemoresistanceviaepigeneticactivationofbcl2l10inovariancancer AT huipeng nuclearlncrnacerna1enhancesthecisplatininducedcellapoptosisandovercomeschemoresistanceviaepigeneticactivationofbcl2l10inovariancancer AT ningyang nuclearlncrnacerna1enhancesthecisplatininducedcellapoptosisandovercomeschemoresistanceviaepigeneticactivationofbcl2l10inovariancancer AT zhenpingliu nuclearlncrnacerna1enhancesthecisplatininducedcellapoptosisandovercomeschemoresistanceviaepigeneticactivationofbcl2l10inovariancancer AT weilu nuclearlncrnacerna1enhancesthecisplatininducedcellapoptosisandovercomeschemoresistanceviaepigeneticactivationofbcl2l10inovariancancer |